Market Overview:
The global peptic ulcers treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of peptic ulcers, rising awareness about available treatments, and growing demand for minimally invasive procedures. By type, the ASP-6537 segment is expected to account for the largest share of the global market in 2018. By application, the hospital segment is expected to account for the largest share of the global market in 2018.
Product Definition:
A peptic ulcer is a sore in the lining of the stomach or intestine. The most common symptom of a peptic ulcer is burning pain in the upper abdomen. Peptic ulcers are usually treated with drugs that reduce acid production in the stomach.
ASP-6537:
ASP-6537 is a selective inhibitor of prostaglandin E2. Prostaglandins are known to cause gastric ulcers and protect the stomach against damage. ASP-6537 has been found to be more effective than indomethacin in preventing ulcerative colitis, thus increasing its market share in the treatment of peptic ulcers.
BGC-001:
BGC-001 is a novel, double-blind, Placebo controlled study drug for the treatment of peptic ulcer disease. It is an oral drug that works by decreasing the acidity of stomach lining and thus reduces the damage to cells caused by excessive acid production. The active ingredient in BGC-001 has been proven to be more effective than histrelin and lansoprazole in clinical trials for treating gastric ulcers.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and others. Hospital was estimated as the largest segment in 2017 owing to rising prevalence of peptic ulcers and increasing investments by governments for developing hospitals with advanced facilities for treatment. For instance, Aspire Medicity Ulcer Care Hospital developed & managed by Torrent Health Limited is a state-of-the-art facility at Nairobi, Kenya that offers a wide range of services including endoscopic procedures for peptic ulcers.
Clinic was estimated as the second largest segment due to growing awareness about early diagnosis and treatment options among general practitioners (GPs). Furthermore, initiatives such as PEPFAR¢â‚¬â„¢s HIV/AIDS program in Africa that funds clinics at a district level has also played an important role in treating ulcers through regular checkups.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising healthcare expenditure are some factors driving the growth of this region. For instance, as per an article published in Clinical Gastroenterology & Hepatology in 2015; nearly 50% of patients with gastric cancer are diagnosed at a late stage which is associated with a higher mortality rate. Thus, increasing awareness about Peptic Ulcer Disease (PUD) and raising funds for research purposes is expected to drive the growth of this region over the forecast period.
Asia Pacific market was valued at USD X billion in 2017 owing to high unmet clinical needs coupled with rapidly growing economy.
Growth Factors:
- Increasing incidence of peptic ulcers
- Rising awareness about the treatment options for peptic ulcers
- Growing demand for minimally invasive procedures for the treatment of peptic ulcers
- Technological advancements in the field of peptic ulcer treatment
- increasing prevalence of Helicobacter pylori infection
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptic Ulcers Treatment Market Research Report
By Type
ASP-6537, BGC-001, DWJ-206, DWP-14012, Others
By Application
Hospital, Clinic, Others
By Companies
Ache Laboratorios Farmaceuticos S/A, Astellas Pharma Inc., ChoDang Pharm Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Kukje Pharmaceutical Industry Co., Ltd., RaQualia Pharma Inc., Sequella, Inc., Sihuan Pharmaceutical Holdings Group Ltd., Sinil Pharmaceutical Co., Ltd, Yooyoung Pharmaceutical Co., Ltd, Ache Laboratorios Farmaceuticos S/A
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Peptic Ulcers Treatment Market Report Segments:
The global Peptic Ulcers Treatment market is segmented on the basis of:
Types
ASP-6537, BGC-001, DWJ-206, DWP-14012, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ache Laboratorios Farmaceuticos S/A
- Astellas Pharma Inc.
- ChoDang Pharm Co., Ltd.
- Daewoong Pharmaceutical Co., Ltd.
- Kukje Pharmaceutical Industry Co., Ltd.
- RaQualia Pharma Inc.
- Sequella, Inc.
- Sihuan Pharmaceutical Holdings Group Ltd.
- Sinil Pharmaceutical Co., Ltd
- Yooyoung Pharmaceutical Co., Ltd
- Ache Laboratorios Farmaceuticos S/A
Highlights of The Peptic Ulcers Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ASP-6537
- BGC-001
- DWJ-206
- DWP-14012
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptic Ulcers Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peptic ulcers are a type of stomach infection that can cause pain and bleeding. Treatment usually includes antibiotics and pain relief. In some cases, surgery may be necessary to remove the ulcer.
Some of the major companies in the peptic ulcers treatment market are Ache Laboratorios Farmaceuticos S/A, Astellas Pharma Inc., ChoDang Pharm Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Kukje Pharmaceutical Industry Co., Ltd., RaQualia Pharma Inc., Sequella, Inc., Sihuan Pharmaceutical Holdings Group Ltd., Sinil Pharmaceutical Co., Ltd, Yooyoung Pharmaceutical Co., Ltd, Ache Laboratorios Farmaceuticos S/A.
The peptic ulcers treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peptic Ulcers Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Peptic Ulcers Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Peptic Ulcers Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Peptic Ulcers Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Peptic Ulcers Treatment Market Size & Forecast, 2020-2028 4.5.1 Peptic Ulcers Treatment Market Size and Y-o-Y Growth 4.5.2 Peptic Ulcers Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ASP-6537
5.2.2 BGC-001
5.2.3 DWJ-206
5.2.4 DWP-14012
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peptic Ulcers Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peptic Ulcers Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ASP-6537
9.6.2 BGC-001
9.6.3 DWJ-206
9.6.4 DWP-14012
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ASP-6537
10.6.2 BGC-001
10.6.3 DWJ-206
10.6.4 DWP-14012
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ASP-6537
11.6.2 BGC-001
11.6.3 DWJ-206
11.6.4 DWP-14012
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ASP-6537
12.6.2 BGC-001
12.6.3 DWJ-206
12.6.4 DWP-14012
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ASP-6537
13.6.2 BGC-001
13.6.3 DWJ-206
13.6.4 DWP-14012
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peptic Ulcers Treatment Market: Competitive Dashboard
14.2 Global Peptic Ulcers Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ache Laboratorios Farmaceuticos S/A
14.3.2 Astellas Pharma Inc.
14.3.3 ChoDang Pharm Co., Ltd.
14.3.4 Daewoong Pharmaceutical Co., Ltd.
14.3.5 Kukje Pharmaceutical Industry Co., Ltd.
14.3.6 RaQualia Pharma Inc.
14.3.7 Sequella, Inc.
14.3.8 Sihuan Pharmaceutical Holdings Group Ltd.
14.3.9 Sinil Pharmaceutical Co., Ltd
14.3.10 Yooyoung Pharmaceutical Co., Ltd
14.3.11 Ache Laboratorios Farmaceuticos S/A